Last reviewed · How we verify

NCT05879289

Evaluation of the Effectiveness of the Anti-aging Effect of a Supplement in Improving Skin Conditions

Completed NA Last updated 30 May 2023
What this trial tests

NA trial testing A power supplement in Aging Well in 30 participants. Completed in 17 May 2022.

Timeline
25 January 2022
Primary endpoint
17 May 2022
17 May 2022

Quick facts

Lead sponsorFarmoquimica S.A.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment30
Start date25 January 2022
Primary completion17 May 2022
Estimated completion17 May 2022
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Farmoquimica S.A. — full company profile →

Who can join

Adults 35 to 65, female only, with Aging Well. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A unicentric, blind, non-comparative clinical study to evaluate facial and body anti-aging efficacy of a supplement in female participants through clinical, subjective and instrumental evaluations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aging Well

Currently open trials in the same condition.

Other Farmoquimica S.A. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05879289.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing